Filing Details
- Accession Number:
- 0001225208-24-004316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-19 16:41:02
- Reporting Period:
- 2024-03-18
- Accepted Time:
- 2024-03-19 16:41:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1566094 | B. Jeffrey Mirviss | 300 Boston Scientific Way Marlborough MA 01752-1234 | Evp&Pres, Periph Intervent | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-18 | 14,506 | $66.45 | 58,098 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 25, 2023.
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.26 to $66.791, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.